Preventive Care
Latest News
3D-printed meds customize the exact dose for sick children
Researchers hope to print precisely dosed tablets in child-friendly shapes and flavors.
From the Journals
‘Missed opportunities’ for accurate diagnosing of women with vaginitis
Study suggests that clinicians are not engaging the standard of care for testing and diagnosing vaginitis.
Commentary
Mammography breast density reporting: What it means for clinicians
Should this be something that we talk to patients about, utilizing shared decision-making to decide about whether follow-up testing is necessary...
Latest News
Making one key connection may increase HPV vax uptake
The understanding that human papillomavirus causes oropharyngeal squamous cell carcinoma (OPSCC) has been linked with increased likelihood of...
Conference Coverage
Screening finds high rates of CVD in diabetes, COPD patients
The study tested a “very simple” symptom questionnaire as the initial screening phase, yet resulted in a CVD diagnostic rate that was two- to...
Commentary
Really? Cancer screening doesn’t save lives?
The screening tests are unlikely to help most people because most people will not die of the particular type of cancer being screened for. But it...
From the Journals
AAP’s hearing test clinical update is the first since 2009
Guidance updates developmental milestones and screening recommendations and changes terminology to eliminate references such as “failed” and “...
Commentary
A nurse’s view: Blood test for severe preeclampsia will save lives
The test’s ability to predict severe preeclampsia within 2 weeks can help save lives.
Latest News
Continuous glucose monitors for pregnant patients?
The benefits of these technologies for patients with gestational diabetes are unclear in consideration of the...
From the Journals
Aspirin for secondary CVD prevention underused worldwide
“We had hoped that the rates of aspirin use for secondary prevention would have increased after decades of effort to promote cardiovascular health...
From the Journals
FDA approves first RSV vaccine for pregnancy
The vaccine can be given between weeks 32 and 36 of pregnancy and is designed to protect infants from the virus from birth to 6 months of age.